Vaccination of puppies with a lipid-formulated plasmid vaccine protects against a severe canine distemper virus challenge

Vaccine

Volumn 21, Issue 11-12, 2003, Pages 1099-1102

  Fischer, Laurent ^a   Tronel, Jean Philippe ^a   Minke, Jules ^a   Barzu, Simona ^a   Baudu, Philippe ^a   Audonnet, Jean Christophe ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

CDV; DNA vaccine; Dog

Indexed keywords

DISTEMPER VACCINE; DNA VACCINE; LIPID; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS HEMAGGLUTININ;

ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CANINE DISTEMPER MORBILLIVIRUS; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; DOG DISEASE; DRUG FORMULATION; INFECTION PREVENTION; NONHUMAN; PLASMID; PRIORITY JOURNAL; VACCINATION; VIRUS INFECTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; DISTEMPER; DISTEMPER VIRUS, CANINE; DNA, COMPLEMENTARY; DOGS; GENETIC VECTORS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; LIPIDS; NEUTRALIZATION TESTS; PHOSPHATIDYLETHANOLAMINES; QUATERNARY AMMONIUM COMPOUNDS; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINATION; VACCINES, DNA; VIRAL VACCINES;

EID: 0037424140     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00608-4     Document Type: Article

References (30)

1. Wolff J.A., Malone R.W., Williams P.et al. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
2. Tang D.C., De Vit M., Johnston S.A. Genetic immunisation is a simple method for eliciting an immune response. Nature. 356:1992;152-154.
3. Robinson H.L., Hunt L.A., Webster R.G. Protection against lethal influenza challenge by immunisation with a haemagglutinin-expressing plasmid DNA. Vaccine. 11:1993;957-960.
4. van Drunen Littel-van den Hurk S., Loehr B.I., Babiuk L.A. Immunisation of livestock with DNA vaccines: current studies and future prospects. Vaccine. 19:2001;2474-2479.
5. Krishnan B.R. Current status of DNA vaccines in veterinary medicine. Adv. Drug Deliv. Rev. 15:2000;3-11.
6. Robinson H.L. DNA vaccines: basic mechanism and immune responses. Int. J. Mol. Med. 4:1999;549-555. [review].
7. Kodihalli S., Goto H., Kobasa D.L., Krauss S., Kawaoka Y., Webster R.G. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1influenza virus infection in mice. J. Virol. 73:1999;2094-2098.
8. Konishi E, Yamaoka M, Khin-Sane-Win, Kurane I, Takada K, Mason PW. The anamnestic neutralising antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus pre-membrane and envelope genes. J Virol 1999;73:5527-34.
9. Johnson P.A., Conway M.A., Daly J., Nicolson C., Robertson J., Mills K.H. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses. J. Gen. Virol. 81:2000;1737-1745.
10. Otten G.R., Doe B., Schaefer M.et al. Relative potency of cellular and humoural immune responses induced by DNA vaccination. Intervirology. 43:2000;227-232.
11. Wang R., Doolan D.L., Le T.P.et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science. 282:1998;476-480.
12. Somasundaram C., Takamatsu H., Andreoni C.et al. Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus. Vet. Immmunol. Immunopathol. 70:1999;277-287.
13. Drew D.R., Boyle J.S., Lew A.M., Lightowlers M.W., Chaplin P.J., Strugnell R.A. The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep. Vaccine. 19:2001;4417-4428.
14. Green T.D., Newton B.R., Rota P.A., Xu Y., Robinson H.L., Ross T.M. C3d enhancement of neutralising antibodies to measles hemagglutinin. Vaccine. 20:2001;242-248.
15. Lunn D.P., Soboll G., Schram B.R.et al. Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene. Vaccine. 17:1999;2245-2258.
16. Ulmer J.B., DeWitt C.M., Chastain M.et al. Enhancement of DNA vaccine potency using conventional aluminium adjuvants. Vaccine. 18:1999;18-28.
17. Sasaki S., Tsuji T., Hamajima K. Monophosphoryl lipid A enhances both humoural and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1. Infect. Immun. 65:1997;3520-3528.
18. Lodmell D.L., Ray N.B., Ulrich J.T., Ewalt L.C. DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL). Vaccine. 18:2000;1059-1066.
19. Hartikka J., Bozoukova V., Ferrari M.et al. Vaxfectin enhances the humoural immune response to plasmid DNA-encoded antigens. Vaccine. 19:2001;1911-1923.
20. Barrett T. Morbillivirus infections, with special emphasis on morbilliviruses of carnivores. Vet. Microbiol. 69:1999;3-13.
21. Pardo M.C., Bauman J.E., Mackowiak M. Protection of dogs against canine distemper by vaccination with a canarypox virus recombinant expressing canine distemper virus fusion and hemagglutinin glycoproteins. Am. J. Vet. Res. 58:1997;833-836.
22. Cherpillod P., Tipold A., Griot-Wenk M.et al. DNA vaccine encoding nucleocapsid and surface proteins of wild type canine distemper virus protects its natural host against distemper. Vaccine. 18:2000;2927-2936.
23. Sixt N., Cardoso A., Vallier A., Fayolle J., Buckland R., Wild T.F. Canine distemper virus DNA vaccination induces humoural and cellular immunity and protects against a lethal intracerebral challenge. J. Virol. 72:1998;8472-8476.
24. Polack F.P., Lee S.H., Permar S.et al. Successful DNA immunisation against measles: neutralising antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles. Nat. Med. 6:2000;776-781.
25. Perrie Y., Frederik P.M., Gregoriadis G. Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine. 19:2001;3301-3310.
26. Daniels G.A., Galanis E. Immunotherapy of renal cell carcinoma by intratumoural administration of an IL-2cDNA/DMRIE/DOPE lipid complex. Curr. Opin. Mol. Ther. 3:2001;70-76.
27. Stopeck A.T., Jones A., Hersh E.M.et al. Phase II study of direct intralesional gene transfer of allovectin-7, anHLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma. Clin. Cancer Res. 7:2001;2285-2291.
28. Hartikka J., Sawdey M., Cornefert-Jensen F.et al. An improved plasmid DNA expression vector for direct injection into skeletalmuscle. Hum. Gene Ther. 7:1996;1205-1217.
29. Klavinskis L.S., Barnfield C., Gao L., Parker S. Intranasal immunisation with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts. J. Immunol. 162:1999;254-262.
30. Van Rooij E.M.A., Haagmans B.L., de Visser Y.E., de Bruin M.G.M., Boersma W., Bianchi A.T.J. Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs. Vet. Immmunol. Immunopathol. 66:1998;113-126.